Peritoneal MRI in patients undergoing cytoreductive surgery and HIPEC: History, clinical applications, and implementation

Eur J Surg Oncol. 2021 Jan;47(1):65-74. doi: 10.1016/j.ejso.2019.02.030. Epub 2019 Feb 28.

Abstract

MR imaging provides considerable advantages in the evaluation of patients with peritoneal metastases. A standardized peritoneal MRI protocol, including diffusion-weighted and gadolinium-enhanced sequences, allows an efficient exploration of small peritoneal tumors that are often missed on other imaging tests. In experienced hands, a dedicated reading allows producing a quantitative and qualitative evaluation of lesional localization to better assist surgeons in the selection of candidates for curative surgery by evaluating the possibility of complete resection, and to plan the surgical procedure. Based on a close collaboration between oncologic surgeon and radiologist, MRI provides a powerful tool for accurate preoperative imaging in patients being considered for curative surgery but also in their surveillance to detect an early recurrence.

Keywords: Peritoneal cancer index; Peritoneal carcinomatosis; Peritoneal metastases; Preoperative assessment; Pseudomyxoma peritonei; Resectability.

Publication types

  • Review

MeSH terms

  • Combined Modality Therapy
  • Contrast Media
  • Cytoreduction Surgical Procedures*
  • Humans
  • Hyperthermic Intraperitoneal Chemotherapy*
  • Magnetic Resonance Imaging*
  • Patient Selection
  • Peritoneal Neoplasms / diagnostic imaging*
  • Peritoneal Neoplasms / secondary
  • Peritoneal Neoplasms / therapy*
  • Preoperative Care
  • Pseudomyxoma Peritonei / diagnostic imaging*
  • Pseudomyxoma Peritonei / secondary
  • Pseudomyxoma Peritonei / therapy*

Substances

  • Contrast Media